HIV Drug Therapy Glasgow 2026 – The Global Forum for Advances in HIV Treatment, Clinical Research & Patient Care
HIV Drug Therapy Glasgow 2026 is one of the world’s most influential international conferences dedicated to HIV treatment, prevention, and clinical management. Hosted in the United Kingdom, the event brings together leading clinicians, researchers, scientists, public health experts, and healthcare professionals focused on improving outcomes for people living with HIV through evidence-based therapy and innovation.
For exhibitors, the conference offers direct access to key opinion leaders, infectious disease specialists, researchers, and organizations shaping global HIV treatment strategies.
Event Overview
Event Name: HIV Drug Therapy Glasgow
Start Date: November 8, 2026
End Date: November 11, 2026
Venue: Scottish Event Campus
Venue Address: Exhibition Way, Glasgow G3 8YW, United Kingdom
City: Glasgow
Country: United Kingdom
Event Website: https://www.hivglasgow.org/?utm_source=alsett.com
Venue Website: http://www.sec.co.uk/?utm_source=alsett.com
ExpoMax360 Listing:
https://atlas.expomax360.com/event/hiv-drug-therapy-glasgow/?utm_source=alsett&utm_medium=header_sponsor&utm_campaign=expomax360
Introduction
HIV Drug Therapy Glasgow is internationally recognized as a premier scientific meeting focused on antiretroviral therapy (ART), HIV prevention, comorbidities, and long-term management of HIV infection. The conference plays a critical role in translating the latest research into clinical practice and shaping global treatment guidelines.
Attendees include:
infectious disease physicians & HIV specialists
clinical researchers & trial investigators
pharmacists & treatment program leaders
public health and policy professionals
virologists & immunologists
nurses and allied healthcare professionals
pharmaceutical and medical research organizations
The event is known for its rigorous scientific program and high-impact clinical discussions.
1. Antiretroviral Therapy & Treatment Optimization
A central focus of the conference is the evolution of HIV treatment strategies, including:
next-generation antiretroviral therapies
long-acting injectable treatments
treatment simplification and dual therapy
resistance management and sequencing strategies
individualized treatment approaches
optimizing adherence and durability
These sessions help clinicians apply the latest evidence to real-world patient care.
2. HIV Prevention, PrEP & Public Health Strategies
The conference also addresses prevention and population-level approaches, featuring discussions on:
pre-exposure prophylaxis (PrEP) developments
post-exposure prophylaxis (PEP) strategies
treatment as prevention (U=U)
community-based prevention models
health equity and access to care
global prevention initiatives
These topics are essential to reducing new HIV infections worldwide.
3. Comorbidities, Aging & Long-Term HIV Management
As people with HIV live longer, long-term care has become increasingly complex. The program explores:
cardiovascular, metabolic & renal comorbidities
neurocognitive health and mental well-being
drug–drug interactions
cancer risk and screening
aging with HIV and quality of life
multidisciplinary care models
These sessions support comprehensive, patient-centered care.
4. Clinical Research, Trials & Translational Science
HIV Drug Therapy Glasgow is a key platform for presenting new scientific data, including:
late-breaking clinical trial results
novel therapeutic targets
cure research and remission strategies
vaccine research updates
translational science bridging lab and clinic
real-world evidence studies
Researchers and clinicians engage in data-driven discussions that influence future research directions.
5. Global Policy, Guidelines & Healthcare Systems
The conference also examines the broader context of HIV care, including:
updates to international treatment guidelines
policy and regulatory considerations
healthcare system challenges
global access to medicines
implementation science and scale-up strategies
collaboration between clinical, public health & community sectors
These discussions help align scientific progress with real-world implementation.
Final Thoughts
HIV Drug Therapy Glasgow 2026 remains a cornerstone event in the global HIV community, driving progress in treatment, prevention, and long-term care. With its strong scientific focus, high-level expertise, and international participation, the conference provides exceptional value for clinicians, researchers, and organizations committed to ending the HIV epidemic.
Hosted at the Scottish Event Campus, the event continues to shape the future of HIV medicine through collaboration, evidence, and innovation.
HIV treatment conference, antiretroviral therapy, HIV clinical research, HIV Drug Therapy Glasgow 2026, infectious disease meeting, global HIV medicine










